First up , to get some core information Gilly try these links :
This one will provide you with a shop window view of Unilife , The Company , and importantly its range of innovative products :
http://www.unilife.com/
The following links to some analyst reports will start to give you some colour :
http://www.griffinsecurities.com/viewpdf.php?docid=822
http://www.griffinsecurities.com/viewpdf.php?docid=861
http://www.griffinsecurities.com/viewpdf.php?docid=865
Finally , many well informed investors on the UNS thread will help out with your questions , no doubt !
To start the ball rolling :
UNS is still in start up mode ; meaningful recurrent revenue from sale/production is just kicking in ;
UNS expenditure is> revenue/profit
Many of their business transactions are still subject to confidentiality .
UNS has a low pool of operating $$$ atm ; some will argue ( me included) that is about to change ??
The plusses :
It is operating in a sector with 40% net margins ;
UNS is partnered by Sanofi a multi $$$B global pharma ;
UNS has an exciting range of innovative products at the cutting edge of biologic medicines .
UNS has already established several multi-year ( 10-15) year contacts for some of its products ..with major pharma .
Now go your hardest , do some homework , tell us what you think ; ask some questions and the gang will fill you in .
regards
Q
- Forums
- ASX - By Stock
- UNS
- Inquiry
UNS
unilife corporation
Add to My Watchlist
0.00%
!
0.5¢

Inquiry, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online